Therapeutic Approach

Archive: August, 2015

Ritter Pharmaceuticals Retains William M. Merino as Senior Clinical and Regulatory Advisor

LOS ANGELES (August 5, 2015) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that William (Bill) Merino has been retained as a senior clinical and regulatory advisor to the company. Dr. Merino has extensive experience with the U.S. […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD